Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects
Launched by NEW YORK INSTITUTE OF TECHNOLOGY · Nov 1, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to explore whether osteopathic manipulative treatment (OMT) can help improve sleep quality in people with Parkinson's disease (PD). Parkinson's disease can cause symptoms like tremors and stiffness, which often lead to sleep difficulties. This study aims to see if OMT, a hands-on treatment method, can enhance not just sleep quality, but also cognitive function and daily activities for those with PD. Participants will be divided into two groups: one receiving OMT and the other receiving a light touch treatment for comparison. Researchers will use sleep surveys and devices like Fitbits to track improvements.
To be eligible for the trial, participants must have a confirmed diagnosis of Parkinson's disease, experience sleep disturbances, and be able to perform a few basic tasks, such as lying down in different positions and wearing a Fitbit. However, people on certain medications that affect sleep or those with other sleep disorders won't be able to participate. This trial could potentially show that OMT is a helpful option for improving sleep in people with Parkinson's disease, offering a possible new avenue for better management of their condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must have a diagnosis of Parkinson's disease as per a neurologist
- • Severity of 0-3 on the Hoehn and Yahr (H-Y) Scale
- • Able to receive OMM
- • Able to be in a supine and prone position.
- • Able to wear a Fitbit watch and an oxygen saturation ring for the duration of the study (including when sleeping).
- • Have sleep disturbance complaints.
- Exclusion Criteria:
- • Patients on medications that affect sleep
- • Have a pre-existing sleep disorder diagnosis
- • Those who have a concurrent neurological diagnosis that would confound sleep patterns (ie. narcolepsy)
- • Contraindications to the OMM techniques used in this protocol
- • Severity of 4 and 5 on the Hoehn and Yahr Scale
About New York Institute Of Technology
The New York Institute of Technology (NYIT) is a distinguished institution recognized for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, NYIT leverages its expertise in health sciences, engineering, and technology to conduct rigorous studies that aim to improve patient outcomes and address pressing medical challenges. The institute is dedicated to fostering a conducive environment for clinical research, ensuring compliance with ethical standards, and promoting the translation of findings into practical applications in the healthcare sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported